Transition to Psychosis: Evaluation of the First-Degree Relatives of Patients with Schizophrenia
-
Mehdi Hormozpour
,
Homayoun Amini
,
Sara Pajouhanfar
,
Masoomeh Faghankhani
,
Arash Rahmani
,
Vandad Sharifi
Abstract
Objective: Schizophrenia and other psychoses have devastating personal and social impacts and many efforts have been devoted to study prodromal syndromes for psychosis in order to achieve earlier detection and interventions. However, only few studies have been performed in developing countries on this subject, and there is a dearth of evidence in the Iranian population. In this study, we focused on conversion rate to psychosis and changes in prodromal symptoms in a group of first-degree relatives of patients with schizophrenia and to compare the conversion rate in those with and without prodromal symptoms as assessed by the Structured Interview for Prodromal Syndromes (SIPS) and Scale of Prodromal Symptoms (SOPS).
Method: Participants were the first-degree relatives of hospitalized patients with schizophrenia at Roozbeh Hospital, Tehran, Iran. At baseline, a trained psychiatrist interviewed the participants using the SIPS and the SOPS and assigned them to high- or low-risk groups either based on the presence of prodromal criteria or seeking mental health services. After 12 months, the same examiner re-evaluated the participants in order to determine the changes in their symptoms and identify the probable transitions to psychosis.
Results: One hundred participants, 50 participants within each of high- or low-risk groups, were recruited at baseline. Eight participants dropped out of the study. At the follow-up, the rate of transition to full psychosis among high-risk group was 13% (95% CI [0.029, 0.23]), whereas none of the low-risk participants developed psychosis. None of the high-risk participants demonstrated attenuation in their prodromal states after a one-year follow-up. In contrast, of the 50 low-risk participants, three experienced prodromal symptoms for psychosis during this period. High-risk participant’s illustrated higher severity in almost all of the SOPS items compared to the low-risk participants at both baseline and follow-up evaluations.
Conclusion: Prodromal syndrome for psychosis based on the SIPS and the SOPS was a predictive factor for transition to psychosis after a 12-month period in a group of first-degree relatives of patients with schizophrenia admitted to a psychiatric hospital in Iran. Conducting further studies on this at-risk population is highly recommended in order to provide practical methods for early screening and therapeutic interventions
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet 2013; 380: 2197-2223.
Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS medicine 2005; 2: 413.
Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, et al. The economic burden of schizophrenia in the United States in 2002. Journal of Clinical Psychiatry 2005.
Frey S. The economic burden of schizophrenia in Germany: A population-based retrospective cohort study using genetic matching. European Psychiatry 2014; 29: 479-489.
Zhai J, Guo X, Chen M, Zhao J, Su Z. An investigation of economic costs of schizophrenia in two areas of China. Int J Ment Health Syst 2013; 7: 26.
Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. The Lancet 2013; 382: 1564-1574.
Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T , Ascher-Svanum H. The personal, societal, and economic burden of schizophrenia in the People’s Republic of China: implications for antipsychotic therapy. ClinicoEconomics and outcomes research: CEOR 2013; 5: 407.
Ekman M, Granstrom O, Omerov S, Jacob J, Landen M. The societal cost of schizophrenia in Sweden. The journal of mental health policy and economics 2013; 16: 13.
Correll CU, Hauser M, Auther AM , Cornblatt BA. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. Journal of Child Psychology and Psychiatry 2010; 51: 390-431.
Bechdolf A, Pukrop R, Köhn D, Tschinkel S, Veith V, Schultze-Lutter F, et al. Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophrenia research 2005; 79: 137-143.
Ruhrmann S, Paruch J, Bechdolf A, Pukrop R, Wagner M, Berning J, et al. Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatrica Scandinavica 2008; 117: 357-368.
Millier A, Schmidt U, Angermeyer M, Chauhan D, Murthy V, Toumi M, et al. Humanistic burden in schizophrenia: a literature review. Journal of psychiatric research 2014; 54: 85-93.
Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia bulletin 1996; 22: 353-370.
Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Australian and New Zealand Journal of Psychiatry 1996; 30: 587-599.
Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC , Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Focus 2004.
Hafner H, Heiden W. The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. European Archives of Psychiatry and Clinical Neuroscience 1999; 249: 14-26.
Häfner H, Maurer K, Löffler W, Bustamante S, Van der Heiden W, Riecher-Rössler A, et al. Onset and early course of schizophrenia. In: eds. Search for the Causes of Schizophrenia. City: Springer; 1995. p. 43-66.
Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of general psychiatry 2012; 69: 220-229.
Pantelis C, Pantelis C, Yücel M, Wood SJ, McGorry PD , Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Australian and New Zealand Journal of Psychiatry 2003; 37: 399-406.
Schimmelmann BG, Huber CG, Lambert M, Cotton S, McGorry PD , Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first- episode psychosis cohort. Journal of psychiatric research 2008; 42: 982-990.
McGlashan TH , Johannessen JO. Early detection and intervention with schizophrenia: rationale. Schizophrenia bulletin 1996; 22: 201-222.
Harrigan SM, McGorry P, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychological medicine 2003; 33: 97-110.
Norman RM , Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychological medicine 2001; 31: 381-400.
Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly 1999; 70: 273-287.
McGlashan TH, Miller TJ, Woods SW, Hoffman RE , Davidson L. Instrument for the assessment of prodromal symptoms and states. In: Eds. Early intervention in psychotic disorders. City: Springer; 2001. p. 135-149.
Skeate A, Patterson P and Birchwood M. Transition to psychosis in a high-risk sample: the experience of ED: IT, Birmingham, UK. In: editor.^editors. Schizophrenia Research; 2004: ELSEVIER SCIENCE BV PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS; 2004. p. 44-44.
Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry 2002; 159: 863-865.
Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Archives of general psychiatry 2001; 58: 158-164.
Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophrenia bulletin 2009; 35: 894-908.
Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of general psychiatry 2008; 65: 28-37.
Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly 1999; 70: 273-287.
Hall RC. Global assessment of functioning: a modified scale. Psychosomatics 1995; 36: 267-275.
Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 2003; 29: 703-715.
Fernández P, Ortega J, García P, Gutiérrez A, García A, Bobes J, et al. Predictive validity of the Scale of Prodromal Symptoms (SOPS). Actas Esp Psiquiatr 2006; 34: 216-223.
Jung MH, Jang JH, Kang D-H, Choi J-S, Shin NY, Kim HS, et al. The reliability and validity of the Korean version of the structured interview for prodromal syndrome. Psychiatry investigation 2010; 7: 257-263.
Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, et al. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophrenia bulletin 2012; 38: 1225-1233.
Gerstenberg M, Theodoridou A, Traber-Walker N, Franscini M, Wotruba D, Metzler S, et al. Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms. Psychological medicine 2015: 1-10.
Manninen M, Lindgren M, Therman S, Huttunen M, Ebeling H, Moilanen I, et al. Clinical high‐risk state does not predict later psychosis in a delinquent adolescent population. Early intervention in psychiatry 2014; 8: 87-90.
| Files | ||
| Issue | Vol 11 No 1 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| psychosis schizophrenia prodrome relatives | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
